Glucose Biosensors Market Forecast Analysis Through 2030 With Insights On Industry Expansion

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Glucose Biosensors Market By 2030 Based On Its 2026 Value?

The glucose biosensors market has experienced significant expansion in recent years. Projections indicate its size will expand from $16.72 billion in 2025 to $18.83 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.6%. Historically, this expansion has been driven by factors such as the rising incidence of diabetes, a greater need for at-home monitoring solutions, advancements in biosensor sensitivity, the broadening scope of point-of-care diagnostics, and increased patient knowledge regarding glucose management.

The glucose biosensors market is projected to experience significant expansion over the coming years. By 2030, this market is anticipated to reach $30.88 billion, demonstrating a compound annual growth rate (CAGR) of 13.2%. Factors contributing to this growth during the projection period include the wider acceptance of digital diabetes management tools, a heightened demand for non-invasive monitoring methods, the proliferation of personalized healthcare offerings, increased financial commitments to biosensor research and development, and the expanded application of AI-driven glucose analytics. Key developments expected within this timeframe encompass the greater uptake of continuous glucose monitoring systems, a surge in demand for wearable glucose biosensors, deeper integration with mobile health platforms, the advancement of non-invasive glucose monitoring technologies, and a sharper emphasis on the precision of real-time data.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10708&type=smp

Which Growth Factors Are Strengthening The Glucose Biosensors Market Landscape?

The escalating occurrence of diabetes is anticipated to stimulate the expansion of the glucose biosensors market in the foreseeable future. Diabetes is an incurable condition that develops when the pancreas fails to produce adequate insulin or when the body cannot effectively utilize the insulin it generates. Diabetic patients use glucose biosensors to track their blood glucose levels, which allows them to monitor these levels conveniently and regularly, assisting in medication adjustments for better diabetes management. For instance, in June 2024, the National Health Service, a UK-based government department, stated that in 2023, the NHS identified an additional 549,000 individuals in England at risk of developing type 2 diabetes. This increased the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marks a substantial increase compared to 3,065,825 in 2022, underscoring a rise of nearly 20%. Hence, the expanding prevalence of diabetes is a key factor driving the growth of the glucose biosensors market.

How Is The Glucose Biosensors Market Examined Through Segment Analysis?

The glucose biosensors market covered in this report is segmented –

1) By Product Type: Continuous Glucose Monitoring, Self-Monitoring Blood Glucose, Non-Invasive Glucose Monitoring

2) By Technology: Electrochemical Biosensors, Optical Biosensors

3) By End Users: Hospitals, Home Care, Diagnostic Centers and Clinics

Subsegments:

1) By Continuous Glucose Monitoring (CGM): Real-Time CGM Systems, Professional CGM Systems

2) By Self-Monitoring Blood Glucose (SMBG): Glucometers, Test Strips

3) By Non-Invasive Glucose Monitoring: Optical Glucose Sensors, Transdermal Sensors

Which Trends Are Contributing To Changes In The Glucose Biosensors Market?

Major companies operating in the glucose biosensor market are prioritizing the development of innovative solutions, such as next-generation continuous glucose monitoring (CGM) sensors. These advancements are designed to deliver real-time, minute-by-minute glucose readings, often including optional alerts, to enhance diabetes management and patient safety. Next-generation continuous glucose monitoring (CGM) sensors represent advanced devices that continuously measure glucose levels in the interstitial fluid every few minutes, thereby providing real-time data, trend alerts, and optional alarms to assist both patients and clinicians in managing diabetes more effectively. For instance, in August 2025, Abbott Laboratories, a US-based healthcare company, introduced the next-generation FreeStyle Libre 2 Plus sensor. This sensor continuously delivers glucose readings every minute directly to a compatible smartphone without requiring manual scanning. It provides automatic, real-time glucose monitoring, featuring optional customizable alerts for high or low glucose levels. Designed for ease of use, it offers comfortable wear for up to 15 days, is suitable for children aged 2 and older, and can sync with applications to share data with caregivers and healthcare professionals.

Who Are The Businesses Driving Activity In The Glucose Biosensors Market?

Major companies operating in the glucose biosensors market are Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Medtronic plc, Senseonics Holdings, GlySens Incorporated, LifeScan Inc., Ascensia Diabetes Care Holdings Inc., Nova Biomedical Corporation, AgaMatrix Inc., Trividia Health, Ypsomed AG, Universal Biosensors Inc., SD Biosensor Inc., Taidoc Technology Corporation, Nipro Corporation, i-SENS Inc., ACON Laboratories Inc., ARKRAY Inc., Menarini Diagnostics

Access The Complete Glucose Biosensors Market Report:

https://www.thebusinessresearchcompany.com/report/glucose-biosensors-global-market-report

Which Region Commands The Largest Share Of The Glucose Biosensors Market?

North America was the largest region in the glucose biosensors market in 2025. The regions covered in the glucose biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Glucose Biosensors Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/glucose-biosensors-global-market-report

Browse Through More Reports Similar to the Global Glucose Biosensors Market 2026, By The Business Research Company

Industrial Glucose Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-glucose-global-market-report

Blood Glucose Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Biosensors Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosensors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795